SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 20, 2018
(Exact name of registrant as specified in its charter)
|
Nevada |
000-55267 |
98-0661455 |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
|
3651 Lindell Road Suite D # 356 Las Vegas, Nevada |
89103 |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (702) 273-9714
|
___________________________________________________ (Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| [ ] | Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425) |
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
SECTION 8 – Other Events
| Item 8.01 | Other Events |
On June 20, 2018, we issued a press release concerning third party promotional activity. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
The information in Item 8.01 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
SECTION 9 – Financial Statements and Exhibits
| Item 9.01 | Financial Statements and Exhibits |
99.1 Press release, dated June 20, 2018
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Alkame Holdings, Inc.
/s/ Robert Eakle
Robert Eakle
Chief Executive Officer
Date June 20, 2018
| 3 |
Alkame Holdings, Inc. Responds to OTC Markets Regarding Recent Unauthorized Promotional Activity
Las Vegas, Nevada, 20 June 2018 (OTC Markets Press Release) – Alkame Holdings, Inc. (OTC:ALKM) (the “Company”), a health and wellness technology holding company with a focus on patentable, innovative, and eco-friendly consumer products, was alerted by OTC Markets to promotional activities regarding the common stock of the Company. The Company was not involved, in any manner or form, in the promotional activity and only became aware of the promotional activity after being alerted by OTC Markets. Further, NO director, officer, or similar “insider” of the Company was involved in, or had any knowledge of, the promotional activity. The Company is issuing this press release in order to provide OTC Markets, and all investors, with further information regarding the promotional activities.
The Company hereby responds to the following questions:
| 1. | Question : What was the date on which the Company became aware of the promotional activities? |
Response : On 19 June 2018, which was the date on which OTC Markets placed the skull & crossbones symbol of the Company’s page on the OTC Markets portal.
| 2. | Question : What is the Company’s understanding of the promotional activities and their effect on the trading activity of the Company’s securities? |
Response : The Company had no prior knowledge of the promotional activities and was not involved in such activities in any manner or form. The Company’s understanding is that the promotional activities caused the trading volume in shares of the Company’s common stock to increase.
| 3. | Question : What is the Company’s understanding whether the Company, its officers, directors, or any controlling shareholders (defined as shareholders owning 10% or more of the Company’s securities) have, directly or indirectly, been involved in any way (including payment of a third-party) with the creation or distribution of promotional materials related to the Company and its securities? |
Response : The Company, its officers, directors, and controlling shareholders (defined as shareholders owning 10% or more of the Company’s securities) have not, directly or indirectly, been involved in any way (including payment of a third-party) with the creation or distribution of promotional materials related to the Company and its securities.
| 4. | Question : Has the Company, its officers, directors, or any controlling shareholders sold or purchased the Company’s securities within the past 30 days? |
Response : Within the past 30-days neither the Company, its officers, directors, nor any controlling shareholders have sold or purchased the Company’s securities.
The company has been working diligently with our auditors and our filing is in partner review. The filing will be released expeditiously and will document all subsequent events up to the current date.
About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly traded health and wellness technology holding company, with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly-owned subsidiaries market and distribute enhanced waters utilizing an exclusive patented formula and technology to create enhanced water with several unique properties. The organization is diligently building a strong foundation through the launch and acquisition of appropriate business assets, and by pursuing multiple applications to utilize its Intellectual Property by placement into several emerging business sectors, such as the growing aqua-culture industry, consumer bottled water and RTD products, household pet products, horticulture and agriculture applications, as well as many other various water treatment solutions to both new and existing business platforms.
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that the Company will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
For more information, visit http://alkameholdingsinc.com/
Alkame Holdings, Inc. Investor Relations
Website: http://alkameholdingsinc.com/
Email: info@alkameholdingsinc.com
Phone: 702-273-9714